Rising prevalence of cardiac arrhythmia fuels the cardiac ablation catheters market
Catheter ablation procedures are expected to become a prevalent method of treating cardiac arrhythmias owing to the cost-effective and safe treatment method. According to the American Heart Association, around 33.5 million people were suffering from atrial fibrillation globally in 2013. In 2012, the World Health Organization confirmed that cardiovascular diseases accounted for almost 37% of the global non-communicable disease-related mortalities with rising rates of obesity and unhealthy lifestyle. The increase in the prevalence of cardiovascular diseases like atrial fibrillation, atrial flutter, and supraventricular tachycardia, decrease in heart muscle elasticity, decrease in heart output, aging population are the driving factors for the growth of cardiac ablation device markets. According to the study by the American Heart Association in 2017, catheter-based ablation procedures claim 90% success rate with minimum risk of complications allowing patients to resume normal activities within a few days, thereby growing the demand for ablation catheters in surgical procedures.
Cryoablation catheters are expected to fuel the cardiac ablation device market owing to higher success rates and fewer complications
The global cardiac ablation catheters market is segmented on the basis of product type, technology, application, end user, and geography.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients